Considering the fact that Pirfenidone is metabolised throughout the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is probably going to precipitate the toxicity of pirfenidone: concomitant therapy would be to be avoided. Dexamethasone (Hexadecadrol) is usually a glucocorticoid receptor agonist and IL receptor modulator with anti-inflammatory and immunosuppressive https://samuelv013sep7.laowaiblog.com/profile